Evidence map›Paper›PMID 40489719›Full record

Trial reportNeurology2025

Screening and Care for Emotional and Cognitive Problems After Ischemic Stroke: Results of a Multicenter, Cluster-Randomized Controlled Trial.

Jos P L Slenders, Renske M Van Den Berg-Vos, Caroline M Van Heugten, Johanna Visser-Meily, Ruben P A van Eijk, Marthè A A Moonen, Sarah Godefrooij, Vincent I H Kwa, ECO-stroke Study Group

Erratum issuedAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Jos P L SlendersDepartment of Neurology, OLVG, Amsterdam, the Netherlands.ORCID 0000-0002-0314-9797
Renske M Van Den Berg-VosDepartment of Neurology, OLVG, Amsterdam, the Netherlands.
Caroline M Van HeugtenDepartment of Neuropsychology & Psychopharmacology, Faculty of Psychology and Neuroscience (FPN), Maastricht University, the Netherlands.
Johanna Visser-MeilyDepartment of Rehabilitation, Physical Therapy Science & Sports, UMC Utrecht Brain Center, University Medical Center Utrecht, the Netherlands.ORCID 0000-0002-5955-8012
Ruben P A van EijkDepartment of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, the Netherlands; and.ORCID 0000-0002-7132-5967
Marthè A A MoonenDepartment of Neurology, OLVG, Amsterdam, the Netherlands.
Sarah GodefrooijDepartment of Neurology, OLVG, Amsterdam, the Netherlands.
Vincent I H KwaDepartment of Neurology, OLVG, Amsterdam, the Netherlands.ORCID 0000-0002-0942-6206
ECO-stroke Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesEvidence regarding effectiveness of screening for emotional and cognitive problems after stroke is lacking. The primary aim of this study was to test the hypothesis that an intervention focusing on screening and care for emotional and cognitive problems after stroke would improve societal participation at 1 year. Second, we tested the hypotheses that this intervention would improve emotional and cognitive concerns, symptoms of anxiety, symptoms of depression, quality of life (QoL), self-efficacy, and disability.

methodsThis multicenter, patient-masked, cluster-randomized controlled trial assigned clusters (1:1) to intervention or usual care. Clusters were Dutch nonuniversity hospitals with a stroke unit. Ischemic stroke patients aged 18 years and older discharged home without inpatient or outpatient rehabilitation were included. The intervention was a consultation conducted by a specialized stroke nurse at the outpatient neurology clinics at 6 weeks after stroke and included screening for emotional and cognitive problems, screening for participation restrictions, self-management support, and, if needed, referral to rehabilitation services. The primary outcome was societal participation (Restrictions subscale of the Utrecht Scale for Evaluation of Rehabilitation-Participation [USER-P-R]) 1 year after stroke. Secondary outcomes were cognitive and emotional concerns (Checklist for Cognitive and Emotional Consequences following Stroke), symptoms of anxiety (Hospital Anxiety and Depression Scale-Anxiety subscale [HADS-A]), symptoms of depression (HADS-Depression subscale), QoL (5-level version of the EuroQoL 5-dimensional questionnaire [EQ-5D-5L], EuroQoL Visual Analog Scale [EQ-VAS], and Patient-Reported Outcome Measurement Information System [PROMIS-10]), self-efficacy (General Self-Efficacy Scale), and disability (modified Rankin Scale) at 3 and 12 months. Continuous outcome data were analyzed using a mixed model for repeated measures, and ordinal data were analyzed with an ordinal mixed-effects model.

resultsBetween August 14, 2019, and May 11, 2022, a total of 531 patients were included in 12 clusters. The mean age was 70.6 ± 9.7 years, 40.0% were female, and the median NIH Stroke Scale score was 2 (2). Two hundred sixty-four patients were included in 6 hospitals providing the intervention and 267 patients in 6 hospitals providing usual care. Primary analysis demonstrated no difference in USER-P-R score at 1 year after stroke (mean difference [MD] 0.77; 95% CI -2.46 to 4.06; DISCUSSION: Screening for emotional and cognitive problems did not improve societal participation at 1 year after stroke. The potential for improvement in anxiety and QoL warrants further investigation. Cost-effectiveness will be analyzed in our upcoming economic evaluation. TRIAL REGISTRATION INFORMATION: Netherlands Trial Register: NL7295. Registered: September 25, 2018. First patient enrolled: August 14, 2019. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that, in patients recovering from an ischemic stroke, active screening for emotional and cognitive problems at 6 weeks after stroke did not improve societal participation at 1 year.

Indexed as

Affective SymptomsCognitive DysfunctionIschemic StrokeStroke RehabilitationAgedAged, 80 and overAnxietyDepressionFemaleHumansMaleMiddle AgedQuality of LifeSelf Efficacy

Identifiers

PMID40489719
PMCPMC12151330

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.